Latest News & Stories
From COVID-19 to Typhoid: 2026 Sabin Awards Spotlight Vaccine Pioneers
The 2026 Sabin Awards will honor three scientists advancing global health through vaccines, from pandemic response to childhood disease prevention. Professor Uğur Şahin, MD, and Professor Özlem Türeci, MD, will receive the Albert B. Sabin Gold Medal and Dr. Senjuti Saha of Bangladesh will receive the 2026 Rising Star Award.
Sabin Makes New Board Appointments As Two Trustees Complete Terms
The Sabin Vaccine Institute bids farewell to two members of its Board of Trustees who have had significant impact on the growth of the organization and welcomes two new members to the Board.
Sabin Completes Enrollment in All Phase 2 Clinical Trials for cAd3-Marburg Vaccine and cAd3-Sudan Ebolavirus Vaccine
Phase 2 clinical trials to evaluate the safety and immunogenicity of the two monovalent vaccines, both on the cAd3 platform, began in healthy volunteers in Africa in 2023 and in the United States in 2025.
From Research to Action: Solving Real World Health Problems
Sabin’s Applied Epidemiology team turns real‑world data into vaccine action—partnering with local researchers to track disease burden, study vaccine safety and effectiveness, and figure out where vaccines are most needed and how best to use them. We generate practical evidence and share results so decision‑makers can act fast and improve how vaccines are used to prevent disease.
Local Impact, Global Change
Explore how Sabin’s partners drive impact on the ground. Discover their stories here, and check back for updates on new locations and projects.
Making a Case for Vaccines
We make vaccines more accessible, enable innovation and expand immunization across the globe.